Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dextran glucose + sodium chloride is an intravenous combination therapy used for fluid resuscitation and plasma volume expansion in patients with sepsis and septic shock. The solution contains dextran, a complex branched polysaccharide that functions as a colloid to increase plasma oncotic pressure, thereby drawing fluid into the intravascular space and improving microcirculatory blood flow. Glucose (dextrose) is included to provide essential metabolic energy during acute stress, while sodium chloride maintains electrolyte balance and tonicity. This combination is typically administered to stabilize hemodynamic parameters, including cardiac index, mean arterial pressure, and central venous pressure, in critically ill patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextran + glucose + sodium chloride.